Fig. 3From: Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannotKaplan Meier survival analyses according to tamoxifen treatment in patients with a tumor with low CCND1 log2 copy number ratio (a) and high log2 copy number ratio (b)Back to article page
